U.S. Wireless Telecom Stock News

Veradermics (NYSE:MANE) reported positive Phase 2/3 topline results for its oral pattern hair loss candidate VDPHL01, positioning it as a potential first new FDA-approved oral option in this category in almost 30 years. The company also highlighted completion of enrollment in other key clinical studies and recent substantial funding to support ongoing programs. The stock last closed at $107.14, with a 30 day return of 50.1% and a year to date return of 183.8%. For investors watching...

Sea (SE) opened Q1 2026 with total revenue of US$7.1b and basic EPS of US$0.70, while trailing 12 month figures came in at US$25.2b in revenue and basic EPS of US$2.67. Over the recent quarterly run, revenue has moved from US$4.8b in Q1 2025 to US$7.1b in Q1 2026, with basic EPS ranging between US$0.63 and US$0.70 along the way. This sets up a story where margin trends and earnings quality take center stage for investors. See our full analysis for Sea. With the numbers on the table, the next...

Wondering if Varonis Systems at around US$27.01 is a bargain or a value trap? This article breaks down what the current share price might be implying about the company. The stock has had a mixed run, with the share price rising 22.9% over the past month but still down 15.7% year to date and down 40.9% over the last year. Recent coverage has focused on how the stock's weaker 1 year return of 40.9% contrasts with its 3 year return of 12.5%. This puts the recent rebound into perspective. This...

Walmart disclosed in an SEC filing a US$520 million investment in Symbotic (NasdaqGM:SYM). The capital is tied to an AI robotics initiative focused on Walmart’s logistics and supply chain network. The filing highlights a deepening commercial relationship between Walmart and Symbotic beyond prior agreements. For you as an investor, the key context is that Symbotic focuses on AI-driven warehouse automation, targeting high volume retail and logistics operations. Retailers globally are working...

VSE (NasdaqGS:VSEC) has completed its acquisition of Precision Aviation Group, expanding its aviation aftermarket presence across key commercial and rotorcraft segments. The deal is described as immediately accretive to VSE's consolidated Adjusted EBITDA margin and is expected to add revenue scale and deeper technical capabilities. For investors watching VSE at a share price of $180.53, this move comes after a sharp pullback, with the stock down 13.0% over the past week and 15.9% over the...

Determining whether Toll Brothers at US$132.88 still offers value after a strong run, or whether the easier gains may already have occurred, starts with understanding what the current price actually reflects. The stock has pulled back recently, down 6.2% over the past week and 6.0% over the past month. It remains up 27.4% over the past year and 107.0% over three years. Recent coverage has focused on Toll Brothers within the U.S. homebuilding space. This includes commentary on how higher...

On 13 May 2026, The Cigna Group’s President and COO Brian Evanko presented at the Bank of America Global Healthcare Conference, where the company reaffirmed its full-year 2026 outlook for consolidated adjusted income from operations of at least $30.35 per share and highlighted strong first-quarter results. Management also spotlighted efforts to simplify care, including reducing prior authorizations by roughly 15% and launching a rebate-free pharmacy service model, underscoring an emphasis on...

If you are wondering whether HEICO's current share price reflects its true worth, the starting point is understanding how it stacks up on simple valuation checks. The stock last closed at US$291.80, with returns that are down 1.5% over the past week and down 0.7% over the past month, while still up 8.3% over 1 year, 64.7% over 3 years, and 125.6% over 5 years. These moves sit against a backdrop where investors are paying close attention to HEICO's position in the capital goods sector and how...

DTE Energy recently reported first-quarter 2026 results showing revenue of US$5,141 million and net income of US$247 million, and also declared a quarterly dividend of US$1.1650 per share payable on July 15, 2026. At the same time, Jefferies highlighted DTE’s growing data center agreements and supportive regulatory backdrop as key elements reducing business risk and reinforcing its long-term growth pipeline. We’ll now examine how Jefferies’ emphasis on data center-driven growth and risk...

Ziff Davis, Inc. has already reported first-quarter 2026 results, with sales of US$267.64 million and net income of US$22.26 million, while posting a small loss per share from continuing operations but slightly higher overall earnings per share versus a year earlier. Alongside these results, analysts highlighted that revenue and adjusted EBITDA exceeded expectations even as certain Tech and Shopping segments continued to face challenges, drawing attention to management’s ongoing efforts to...

Roku (ROKU) has drawn fresh attention after recent share price swings, with the stock up about 22% over the past month and roughly 52% over the past 3 months, sharpening investor focus on its streaming platform business. See our latest analysis for Roku. The recent 21.64% 1 month share price return and 51.55% 3 month share price return stand alongside a 74.85% 1 year total shareholder return, pointing to momentum that contrasts with the weaker 5 year total shareholder return, which is down...

Veritone (VERI) just posted Q1 2026 results with revenue of US$20.3 million and a basic EPS loss of US$0.21, alongside net income excluding extra items at a loss of US$19.5 million. Together, these figures set a clear snapshot of where growth and profitability stand today. The company has seen quarterly revenue move from US$22.5 million and a basic EPS loss of US$0.41 in Q1 2025 to US$20.3 million and a basic EPS loss of US$0.21 in Q1 2026, giving investors a concrete view of how the top line...

Latest Quarterly Snapshot and What It Means for Investors CB Financial Services (CBFV) opened 2026 with Q1 revenue of about US$14.6 million and basic EPS of roughly US$0.77, while trailing twelve month revenue stood at around US$45.4 million with basic EPS of about US$1.37. This provides a clear view of both the quarter and the recent run rate. The company reported revenue of roughly US$12.1 million in Q1 2025 and US$14.6 million in Q1 2026, with EPS moving from about US$0.37 to US$0.77 over...

First National Bank Alaska reported first-quarter 2026 results showing net interest income of US$48.98 million and net income of US$21.17 million, both higher than a year earlier, and the board declared a US$4.00 per share cash dividend for the second quarter, payable on June 15, 2026. This combination of stronger earnings and a maintained quarterly cash dividend highlights the bank’s ability to generate profit while continuing to return cash to shareholders. Next, we will examine how the...

In early May 2026, US Foods Holding Corp. reported modest year-on-year first-quarter growth in sales and earnings, completed a US$983.6 million buyback program, and reaffirmed its 2026 net sales growth outlook of 4% to 6% despite weather and fuel headwinds. The company also highlighted continued market share gains and an active capital deployment agenda, including further share repurchases and tuck-in acquisitions funded by ongoing cash generation. Against this backdrop, we'll examine how...

First quarter earnings and guidance catch investor attention Royal Caribbean Cruises (RCL) has drawn fresh interest after reporting first quarter 2026 results with higher revenue and net income versus a year earlier, alongside full year guidance pointing to roughly 10% revenue growth. See our latest analysis for Royal Caribbean Cruises. RCL shares closed at US$264.20 and, despite a 2.36% 1 day share price gain after the earnings and guidance update plus the announced US$1.50 quarterly...

Agilent Technologies (A) has been active on several fronts recently, from new collaborations in biopharma analytics to the launch of its 16850 Series portable logic analyzers, giving investors fresh context for assessing the stock. See our latest analysis for Agilent Technologies. Despite fresh product launches and new biopharma collaborations shaping sentiment, Agilent’s share price has eased recently. The 30-day share price return is down 4.05% and the year-to-date share price return is...

Ralph Lauren is curating the USPS American Icons stamp collection, the first time an individual designer has overseen a full official USPS series. The collaboration coincides with preparations for America's 250th anniversary and includes a commemorative capsule collection in Ralph Lauren stores and online. The project links the NYSE:RL brand directly to a high profile national cultural celebration beyond traditional fashion partnerships. For investors tracking NYSE:RL, this project arrives...

In the first quarter of fiscal 2026, Vishay Precision Group reported net revenues of US$84.35 million, a smaller net loss of US$0.319 million compared with a year earlier, and issued second‑quarter revenue guidance of US$85 million to US$90 million, all of which surpassed analyst expectations and reflected broad-based demand across its core segments. Orders exceeded US$100 million, lifting the book-to-bill ratio to 1.21 and backlog to about US$125 million, highlighting strong order...

Labcorp Holdings (LH) is back in focus after announcing an expanded collaboration with Epic, embedding its full diagnostic test menu into Epic's Aura platform to simplify ordering and results for hospitals and health systems. See our latest analysis for Labcorp Holdings. Recent share price performance has been softer, with the stock down 8.52% on a 3 month share price basis and 3.69% over 1 month. However, the 1 year total shareholder return of 6.10% and 3 year total shareholder return of...

The Southern Company recently reported past first-quarter 2026 results, with revenue of US$8,397 million and net income of US$1,356 million, and highlighted a US$26.50 billion Department of Energy loan alongside customer savings from Georgia regulatory agreements. Together, these earnings, financing, and bill-reduction developments underscore how Southern is pairing large-scale infrastructure investment with efforts to limit long-term cost pressure for customers. Next, we’ll examine how this...

In May 2026, Teva Pharmaceutical Industries Limited presented at the Bank of America Global Healthcare Conference in Las Vegas and at BioMed Israel in Tel Aviv, highlighting its central nervous system portfolio and research progress through senior executives Eric A. Hughes and Eran Harary. These appearances came shortly after Teva reported that sales from its central nervous system medicines, including Ajovy, Uzedy, and Austedo, rose very large year-on-year to US$837 million in the first...

On May 12, 2026, Alkermes announced positive topline Phase 3 REVITALYZ results showing that once‑nightly LUMRYZ improved excessive daytime sleepiness and other idiopathic hypersomnia symptoms versus placebo, supporting plans to file a supplemental New Drug Application with the FDA by the end of 2026. A key nuance for investors is that, under an existing settlement, Alkermes cannot market LUMRYZ for idiopathic hypersomnia before March 1, 2028, even if it secures earlier FDA approval. We’ll...

Gilead Sciences (NasdaqGS:GILD) plans to present new liver disease data at the upcoming EASL Congress. The company will showcase pivotal Phase 3 results for Livdelzi (seladelpar) in primary biliary cholangitis. Additional updates will cover progress on investigational hepatitis delta virus treatments, including bulevirtide. Gilead Sciences is putting more attention on its liver disease pipeline, which sits alongside its well known HIV and oncology franchises. The stock trades at $133.05,...